Abstract:Although humanized mouse model is a great tool to study human hematopoiesis, immune function, and various disease, poor myeloid reconstitution has been recognized to be one of the limitations. To solve the problem, various strategies have been examined to express human cytokines in humanized mouse. Drawbacks of using cytokine transgenic mice in generating humanized mice remain unclear, as well as the role of human thymus graft in T cell reconstitution. To examine these 2 different parameters, we generated 4 groups of humanized mice; 1) NOD/SCID/γc-/- [NSG] with human thymus; 2) NSG without human thymus (CD34+ cells alone); 3) human stem cell factor, GM-CSF, and IL-3-transgenic NSG [SGM3] with human thymus; and 4) SGM3 without human thymus. SGM3 humanized mice showed higher human chimerism, better myeloid reconstitution, and aggressive expansion of CD4+ central and effector memory T cells particularly in the absence of human thymus. SGM3 humanized mice had fatal outcome 18 to 22 weeks after transplantation. SGM3 humanized mice showed severe human T cell and macrophage infiltrations to systemic organs including liver, lungs, and spleen. SGM3 mice also showed severe anemia and thrombocytopenia with hypoplastic bone marrow, but reticulocyte count in blood was maintained. These clinical manifestations closely resemble secondary hemophagocytic lymphohistiocytosis in human. Indeed, SGM3 humanized mice showed a significant elevation in inflammatory cytokines, which have been reported to have major roles in the pathogenesis of hemophagocytic lymphohistiocytosis. Although SGM3 humanized mice should not be used to study regular immune response, it may serve as a model to study hemophagocytic lymphohistiocytosis. In addition, our study highlighted the requirement of human thymus to avoid aggressive T cell expansion likely due to the poor negative selection in the mouse thymus. Although humanized mouse model is a great tool to study human hematopoiesis, immune function, and various disease, poor myeloid reconstitution has been recognized to be one of the limitations. To solve the problem, various strategies have been examined to express human cytokines in humanized mouse. Drawbacks of using cytokine transgenic mice in generating humanized mice remain unclear, as well as the role of human thymus graft in T cell reconstitution. To examine these 2 different parameters, we generated 4 groups of humanized mice; 1) NOD/SCID/γc-/- [NSG] with human thymus; 2) NSG without human thymus (CD34+ cells alone); 3) human stem cell factor, GM-CSF, and IL-3-transgenic NSG [SGM3] with human thymus; and 4) SGM3 without human thymus. SGM3 humanized mice showed higher human chimerism, better myeloid reconstitution, and aggressive expansion of CD4+ central and effector memory T cells particularly in the absence of human thymus. SGM3 humanized mice had fatal outcome 18 to 22 weeks after transplantation. SGM3 humanized mice showed severe human T cell and macrophage infiltrations to systemic organs including liver, lungs, and spleen. SGM3 mice also showed severe anemia and thrombocytopenia with hypoplastic bone marrow, but reticulocyte count in blood was maintained. These clinical manifestations closely resemble secondary hemophagocytic lymphohistiocytosis in human. Indeed, SGM3 humanized mice showed a significant elevation in inflammatory cytokines, which have been reported to have major roles in the pathogenesis of hemophagocytic lymphohistiocytosis. Although SGM3 humanized mice should not be used to study regular immune response, it may serve as a model to study hemophagocytic lymphohistiocytosis. In addition, our study highlighted the requirement of human thymus to avoid aggressive T cell expansion likely due to the poor negative selection in the mouse thymus.

Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 mice

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease

Improved multilineage human hematopoietic reconstitution and function in NSGS mice

Abstract 5334: Humanization of NOG mice and next-generation NOG strains to induce lineage-specific differentiation of immune cells for assessment of novel immune cell therapies, check point inhibitors, and immune cell engagers for translational immuno-oncology research

Improvement of multilineage hematopoiesis in hematopoietic stem cell-transferred c-kit mutant NOG-EXL humanized mice

Improved B cell development in humanized NOD -scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3

Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15

Abstract 112: The NSG-Flt3KO; Tg(hFLT3LG); hIL15 mouse strain improves engraftment of innate immune cells post-CD34+ humanization

Abstract 5202: NCG-M Humanized Mice: an Excellent Model for Human Immune Reconstitution of Myeloid Lineages

Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles

Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents

1225 NCG-SGM3 Humanized Mice – an Ideal Model for Human Immune Reconstitution of T and Myeloid Cell Lineages

16 A Novel B2m-deficient Immunodeficient Model Expressing Human IL15 for Preclinical Evaluation of T Cell and NK Cell-Based Therapies

Abstract 4191: Delayed onset of GvHD in PBMC humanized NCG-B2m KO mice provides an enhanced model for oncology studies

Long-term engraftment of adult hematopoietic progenitors in a novel model of humanized mice

MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers

XactMice: Humanizing Mouse Bone Marrow Enables Microenvironment Reconstitution in a Patient-Derived Xenograft Model of Head and Neck Cancer.

Engraftment of adult hematopoietic stem and progenitor cells in a novel model of humanized mice

Abstract 85: Immunomics of immune-deficient mouse models before and after CD34 humanization

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice

Stem Cell Factor, GM-CSF, and IL-3-Transgenic Humanized Mice Develop Fatal Hemophagocytic Lymphohistiocytosis